Use of Sodium-Glucose Cotransporter-2 Inhibitors in Adults Aged ≥65 Years With Type 2 Diabetes and Cardiovascular Disease: A Cross-sectional Study of Different Drug Funding Policies. - McCreary ML; Yeung RO; Manca DP; Greiver M; Singer AG; Lau D (Canadian journal of diabetes, 2024)